Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients

Journal of Immunology

Volumn 156, Issue 11, 1996, Pages 4504-4513

  Prezzi, Caterina ^a   Nuzzo, Maurizio ^a   Meola, Annalisa ^a   Delmastro, Paola ^a   Galfrè, Giovanni ^a   Cortese, Riccardo ^a   Nicosia, Alfredo ^a   Monaci, Paolo ^a  

^a IRBM   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; EPITOPE; HEPATITIS VACCINE;

ANTIBODY SPECIFICITY; ANTIGENICITY; ARTICLE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; PATIENT SELECTION; PRIORITY JOURNAL; VIRUS INFECTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; B-LYMPHOCYTES; BIOLOGICAL MARKERS; EPITOPE MAPPING; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNIZATION; MICE; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; PEPTIDES; VIRAL HEPATITIS VACCINES;

EID: 0029947995     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Alter, H. J. 1995. To C or not to C: these are the questions. Blood 85:1681.
2. Chien, D. Y., Q-L. Choo, R. Ralston, R. Spaete, M. Tong, M. Houghton, and G. Kuo. 1993. Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 342:933.
3. Farci, P., H. Alter, S. Govindarajan, D. Wong, R. Engle, R. Lesniewski, I. Mushahwar, S. M. Desai, R. H. Miller, N. Ogata, and R. H. Purcell. 1992. Lack of protective immunity against reinfection with hepatitis C virus. Science 258: 135.
4. Choo, Q. L., G. Kuo, R. Ralston, A. Weiner, D. Chien, G. Van Nest, J. Han, K. Berger, K. Thudium, C. Kuo, J. Kansopon, J. McFarland, A. Tabrizi, K. Ching, B. Moss, L. B. Cummins, M. Houghton, and E. Muchmore. 1994. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc. Natl. Acad. Sci. USA 91:1294.
5. Folgori, A., R. Tafi, A. Meola, F. Felici, G. Galfrè, R. Cortese, P. Monaci, and A. Nicosia. 1994. A general strategy to identify mimotopes of pathologic antigens using only random peptide libraries and human sera. EMBO J. 13:2236.
6. Meola, A., P. Delmastro, P. Monaci, A. Luzzago, A. Nicosia, F. Felici, R. Cortese, and G. Galfrè. 1995. Derivation of vaccines from mimotopes: immunologic properties of HBsAg mimotopes displayed on filamentous phage. J. Immunol. 154:3162.
7. Felici, F., L. Castagnoli, A. Musacchio, R. Jappelli, and G. Cesareni. 1991. Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector. J. Mol. Biol. 222:301.
8. Luzzago, A., F. Felici, A. Tramontano, A. Pessi, and R. Cortese. 1993. Mimicking of discontinuous epitopes by phage-displayed peptides. I. Epitope mapping of human H ferritin using a phage library of constrained peptides. Gene 128:51.
9. Bullock, W. O., J. M. Fernandez, and J. M. Short. 1987. XL1-Blue: a high efficiency plasmid transforming recA Escherichia coli strain with β-galactosidase selection. Biotechniques 5:376.
10. Dente, L., G. Cesareni, G. Micheli, F. Felici, A. Folgori, A. Luzzago, P. Monaci, A. Nicosia, and P. Delmastro. 1994. Monoclonal antibodies that recognize filamentous phage: useful tools for phage display technology. Gene 148:7.
11. Takamizawa, A., C. Mori, I. Fuke, S. Manabe, S. Murakami, J. Fujita, E. Onoshi, T. Andoh, I. Yoshida, and H. Okayama. 1991. Structure and organization of the hepatitis C virus genome isolated from human carriers. J. Virol. 65:1105.
12. Smith, D. B. 1993. Purification of glutathione S-transferase fusion proteins. Methods Mol. Cell. Biol. 4:220.
13. Geysen, M. 1986. A priori delineation of a peptide which mimics a discontinuous antigenic determinant. Mol. Immunol. 23:709.
14. Khudyakov, Y. E., N. S. Khudyakova, D. L. Jue, S. B. Lambert, S. Fang, and H. A. Fields. 1995. Linear B cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides. Virology 206:666.
15. Okamoto, H., F. Tsuda, A. Machida, E. Munekata, Y. Akahane, Y. Sugai, K. Mashiko, T. Mitsui, T. Tanaka, Y. Miyakawa, and M. Mayumi. 1992. Antibodies against synthetic peptides deduced from the putative core gene for the diagnosis of hepatitis C virus infection. Hepatology 15:180.
16. Cerino, A., P. Boender, N. La Monica, C. Rosa, W. Habets, and M. Mondelli. 1993. A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein. J. Immunol. 151:7005.
17. de la Cruz, V. F., A. A. Lal, and T. F. McCutchan. 1988. Immunogenicity and epitope mapping of foreign sequences via genetically engineered filamentous phage. J. Biol. Chem. 9:4318.
18. Greenwood, J., A. E. Willis, and R. N. Perham. 1991. Multiple display of foreign peptides on a filamentous bacteriophage: peptides from Plasmodium falciparum circumsporozoite protein as antigens. J. Mol. Biol. 220:821.
19. Di Marzo Veronese, F., A. E. Willis, C. Boyer-Thompson, E. Appella, and R. Perham. 1994. Structural mimicry and enhanced immunogenicity of peptide epitopes displayed on filamentous bacteriophage: the V3 loop of HIV-1 gp120. J. Mol. Biol. 243:167.
20. Nobrega, A., M. Haury, A. Grandien, E. Malanchere, A. Sundblad, and A. Coutinho. 1993. Global analysis of antibody repertoires. II. Evidence for specificity, self-selection, and the immunologic "homunculus" of antibodies in normal serum. Eur. J. Immunol. 23:2851.
21. Mouthon, L., A. Nobrega, N. Nicolas, S. V. Kaveri, C. Barreau, A. Coutinho, and M. D. Kazatchkine. 1995. Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults. Proc. Natl. Acad. Sci. USA 92:3839.
22. Smith, G. P. 1991. Surface presentation of protein epitopes using bacteriophage expression system. Curr. Opin. Biotechnol. 2:668.
23. Cortese, R., F. Felici, G. Galfrè, A. Luzzago, P. Monaci, and A. Nicosia. 1994. Epitope discovery using peptide libraries displayed on phage. Trends Biotechnol. 12:262.
24. Felici, F., A. Luzzago, P. Monaci, A. Nicosia, M. Sollazzo, and C. Traboni. 1995. Peptide and protein display on the surface of filamentous bacteriophage. In Biotechnology Annual Review, Vol. 1. M, R. El-Gewely, ed. Eisevier Science E.V., Amsterdam, The Netherlands, p. 149.
25. Muraiso, K., M. Hijikata, S. Ohkoshi, M. J. Cho, M. Kikuchi, N. Kato, and K. A. Shimotono. 1990. A structural protein of hepatitis C virus expressed in Escherichia coli facilitates accurate detection of hepatitis C virus. Biochem. Biophys. Res. Commun. 172:511.
26. Nasoff, M. S., S. L. Zebedee, G. Inchauspe, and A. M. Prince. 1991. Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proc. Natl. Acad. Sci. USA 88:5462.
27. Chiba, J., H. Ohba, Y. Matsuura, Y. Watanabe, T. Katayama, S. Kikuchi, I. Saito, and T. Miyamura. 1991. Serodiagnosis of hepatitis C virus (HCV) infection with an HCV core protein molecularly expressed by a recombinant baculovirus. Proc. Natl. Acad. Sci. USA 88:4641.
28. Hosein, B., C. T. Fang, M. A. Popovsky, J. Ye, M. Zhang, and C. Y. Wang. 1991. Improved Serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein. Proc. Natl. Acad. Sci. USA 88:3647.
29. Salberg, M., U. Ruden, B. Wahren, and L. O. Magnius. 1992. Immunodominant regions within the hepatitis C virus core and putative matrix proteins. J. Clin. Microbiol. 30:1989.
30. Kohara, M., K. Tsukiyama-Kohara, N. Maki, K. Asano, K. Yamaguchi, K. Miki, S. Tanaka, N. Hattori, Y. Matsuura, I. Saito, T. Miyamura, and A. Nomoto. 1992. Expression and characterization of glycoprotein gp35 of hepatitis C virus using recombinant vaccinia virus. J. Gen. Virol. 73:2313.
31. Ralston, R., K. Thudium, K. Berger, C. Kuo, B. Gervase, J. Hall, M. Selby, G. Kuo, M. Houghton, and Q-L. Choo. 1993. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia virus. J. Virol. 67:6753.
32. Mishiro, S., Y. Hoshi, K. Takeda, A. Yoshikawa, T. Gotanda, K. Takahashi, Y. Akahane, H. Yoshizawa, H. Okamoto, F. Tsuda, and D. A. Peterson. 1990. Non-A, non-B hepatitis-specific antibodies directed at host-derived epitope: implication for an autoimmune process. Lancet 336:1400.
33. Magrin, S., A. Craxi, C. Fabiano, G. Florentino, P. Almasio, U. Palazzo, G. Pinzello, G. Provenzano, L. Pagliaro, Q-L. Choo, G. Kuo, A. Polito, J. Han, and M. Houghton. 1991. Hepatitis C virus in "autoimmune" chronic hepatitis. J. Hepatol. 13:364.
34. Lenzi, M., P. J. Johnson, I. G. McFarlane, G. Ballardini, H. M. Smith, B. M. McFarlane, C. Bridger, D. Vergani, F. B. Bianchi, and R. Williams. 1991. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet 338:277.
35. Garson, J. A., M. Lenzi, C. Ring, F. Cassani, G. Ballardini, M. Briggs, R. S. Tedder, and F. B. Bianchi. 1991. Hepatitis C viraemia in adults with type 2 autoimmune hepatitis. J. Med. Virol. 34:223.
36. Tam, J. P. 1988. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide. Proc. Natl. Acad. Sci. USA 85:5409.
37. Zaaijer, H., H. Cuypers, H. Reesink, P. N. Lelie, H. Vrielnk, and C. L. van der Poel. 1994. New immunoblot resolves indeterminate results for antibody to hepatitis C virus. Transfusion 34:184.
38. Oldenburg, K. R., D. Loganathan, I. J. Goldstein, P. G. Schultz, and M. A. Gallop. 1992. Peptide ligands for a sugar binding protein isolated from a random peptide library. Proc. Natl. Acad. Sci. USA 89:5393.
39. Scott, J. K. 1992. Discovering peptide ligands using epitope libraries. Trends Biochem. Sci. 17:241.
40. Hoess, R. H. 1993. Phage display of peptides and protein domains. Curr. Opin. Structural Biol. 3:572.